Enforced expression of METCAM/MUC18 increases tumorigenesis of human prostate cancer LNCaP cells in nude mice

Journal of Urology

Volumn 185, Issue 4, 2011, Pages 1504-1512

  Wu, Guang Jer ^a   Wu, Mei Whey H ^a   Wang, Changsheng ^a   Liu, Yuan ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cell adhesion molecules; disease progression; mice, nude; prostate; prostatic neoplasms

Indexed keywords

CD146 ANTIGEN; CD31 ANTIGEN; CYCLINE; KI 67 ANTIGEN; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL STRAIN LNCAP; CELL SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR VOLUME; UPREGULATION;

ANIMALS; ANTIGENS, CD146; APOPTOSIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROSTATIC NEOPLASMS;

EID: 79952701176     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.11.052     Document Type: Article

References (28)

1. Mohler JL: Cellular motility and prostate carcinoma metastases. Cancer Metastasis Rev 1993; 12: 53.
2. Bernstein LR and Liotta LA: Molecular mediators of interactions with extracellular matrix components in metastasis and angiogenesis. Curr Opin Oncol 1994; 6: 106.
3. Scivolino PJ and Abate-Shen C: Molecular biology of prostate development and prostate cancer. Ann Med 1998; 30: 357.
4. Wu GJ: The role of MUC18 in prostate carcinoma. In: Handbook of Immunohistochemistry and in Situ Hybridization of Human Carcinomas: Molecular Pathology, Colorectal Carcinoma, and Prostate Carcinoma. Edited by MA Hayat. New York: Elsevier Science/Academic Press 2005; vol 2, chapt 3.7, pp 347-358.
5. Lehmann JM, Reithmuller G and Johnson JP: MUC18, a marker of tumor progression in human melanoma. Proc Natl Acad Sci USA: 1989; 86: 9891.
6. Shih IM, Elder DE, Hsu MY et al: Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Am J Patho 1994; 145: 837.
7. Shih IM, Elder DE, Speicher D et al: Isolation and functional characterization of the A32 melanoma-associated antigen. Cancer Res 1994; 54: 2514.
8. Bardin N, George F, Mutin M et al: S-endo1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 1996; 48: 531.
9. Picle SF, Majdic O, Fishe G et al: MUC18/MCAM (CD146), an activation antigen of human T lymphocytes. J Immunol 1997; 158: 2107.
10. Cavallaro U and Christofori G: Cell adhesion and signaling by cadherins and Ig-CAMs in cancer. Nat Rev/Cancer 2005; 4: 118.
11. Wu GJ, Wu MWH, Wang SW et al: Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cells and tissues with malignant progression. Gene 2001; 279: 17.
12. Shih IM: The role of CD146 (Mel-CAM) in biology and pathology. J Pathol 1999; 189: 4.
13. Wu GJ, Varma VA, Wu MWH et al: Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues. Prostate 2001; 48: 305.
14. Wu GJ, Fu P, Chiang CF et al: Increased MUC18 expression correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model. J Urol 2005; 173: 1778.
15. Chiang C, Son EL and Wu GJ: Oral treatment of the TRAMP mice with doxazosin suppresses prostate tumor growth and metastasis. Prostate 2005; 64: 408.
16. Wu GJ, Peng Q, Fu P et al: Ectopical expression of human MUC18 increases metastasis of human prostate cancer cells. Gene 2004; 327: 201.
17. Passaniti A, Isaacs JT, Haney JA et al: Stimulation of human prostatic carcinoma tumor growth in athymic mice and control of migration in culture by extracellular matrix. Int J Cancer 1992; 51: 318.
18. Yang H, Wang SWC, Liu Z et al: Isolation and characterization of murine MUC18 cDNA gene, and correlation of MUC18 expression in murine melanoma cell lines with metastatic ability. Gene 2001; 265: 133.
19. Wu GJ, Fu P, Wang SW et al: Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model. Mol Cancer Res 2008; 6: 1666.
20. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 2000; 100: 57.
21. Datta SR, Brunet A and Greenberg ME: Cellular survival: a play in three AKTs. Genes Devel 1999; 13: 2905.
22. Anfosso F, Bardin N, Vivier E et al: Outside-in signaling pathway linked to CD146 engagement in human endothelial cells. J Biol Chem 2001; 146: 1564.
23. Li G, Kalabis J, Xu X et al: Reciprocal regulation of MELCAM and AKT in human melanoma. Oncogene 2003; 22: 6891.
24. Yan X, Lin Y, Yang D et al: A novel anti-CD146 monoclonal antibody, AA98, inhibits angiogenesis and tumor growth. Blood 2003; 102: 184.
25. Wu GJ: METCAM/MUC18 expression and cancer metastasis. Curr Genomics 2005; 6: 333.
26. Christofori G: Cancer: division of labour. Nature 2007; 446: 735.
27. Wu GJ and Son E: Soluble METCAM/MUC18 blocks angiogenesis during the in vivo tumor formation of human prostate cancer LNCaP cells. Proc Am Assoc Cancer Res 2006; 47: abstract 252.
28. Leslie MC, Zhao YJ, Lachman LB et al: Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis. Gene Ther 2007; 14: 316.